4.4 Review

MicroRNAs: Redefining Mechanisms in Cardiac Disease

Journal

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Volume 56, Issue 6, Pages 589-595

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FJC.0b013e3181f8d173

Keywords

microRNA; heart development; reactive hypertrophy; biomarker

Funding

  1. NHLBI NIH HHS [R01 HL080008, R01 HL059888-06, R01 HL087871-05, R01 HL059888-12, R01 HL087871-01, R01 HL080008-03, R01 HL080008-04, R01 HL059888-10, R01 HL059888-05, RC2 HL102222-02, R01 HL059888, R01 HL059888-11, R01 HL059888-07, R01 HL087871, R01 HL059888-02, R01 HL059888-09A1W1, R01 HL087871-06, R01 HL059888-09A1, R01 HL080008-02, R01 HL059888-01A1, RC2 HL102222, R01 HL080008-01A1, R01 HL087871-04, R01 HL087871-02, R01 HL080008-05, R01 HL059888-03, R01 HL059888-08, RC2 HL102222-01, R01 HL087871-03, R01 HL059888-04, R01 HL080008-06] Funding Source: Medline

Ask authors/readers for more resources

MicroRNAs (miRs) regulate protein expression by inhibiting translation of expressed mRNAs. Targeting by one or more miRs of multiple mRNA transcripts encoding proteins with common functions confers nodal control over cardiac development and stress response. Dynamic coregulation of miRs and their mRNA targets has complicated understanding their biology but also provides opportunities for clinical diagnostics and therapeutics. Here, the biology of miRs is reviewed as it relates to the cardiac system, recent findings are described that illuminate miR control of cardiac development and myofiber identity, and the clinical ramifications of miR expression profiling are illustrated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available